Thursday, May 14, 2015
Gene therapy possibilities for certain heart diseases
Gene therapy possibilities for certain heart diseases. Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University. By bioethicsnewsbot | May 13, 2015
Pill of super-protective 'heavy' fat may be key to eternal youth
Pill of super-protective 'heavy' fat may be key to eternal youth. 13 May 2015 by Jessica Hamzelou, New Scientist, Issue 3021
Mikhail Shchepinov, director of Retrotope, a biotech company based in Los Altos, California, wants eventually to slow down the ageing process. But he is starting with a related problem – treating the inherited movement disorder Friedreich's ataxia, with which ageing shares a mechanism.
The trial launching in June is a safety study. The team will be checking that the doses of heavy fat are well tolerated by 18 people with Friedreich's ataxia.
Mikhail Shchepinov, director of Retrotope, a biotech company based in Los Altos, California, wants eventually to slow down the ageing process. But he is starting with a related problem – treating the inherited movement disorder Friedreich's ataxia, with which ageing shares a mechanism.
The trial launching in June is a safety study. The team will be checking that the doses of heavy fat are well tolerated by 18 people with Friedreich's ataxia.
Metabolomics in Precision Medicine
Magazine Preview: Metabolomics in Precision Medicine. Ian Clift, Ph.D.; From May 15 Issue:Genetic Engineering & Biotechnology News
Dr. Blair studies Friedreich’s ataxia, a disease caused by a mutation in the gene frataxin or by a triplet GAA expansion in intron 1 of the gene
Dr. Blair studies Friedreich’s ataxia, a disease caused by a mutation in the gene frataxin or by a triplet GAA expansion in intron 1 of the gene
Subscribe to:
Posts (Atom)
